Arris Pharmaceutical Corporation is a biotechnology firm based in South San Francisco, California, focused on developing innovative therapies for patients with serious diseases. The company specializes in the discovery and advancement of novel drug candidates, leveraging cutting-edge research in areas such as oncology and neurology. Arris aims to address unmet medical needs through its commitment to scientific excellence and collaboration, striving to bring transformative treatments to market that improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

11 Patents

#98 in South San Francisco, CA

#6,545 in California

#27,540 in US

#51,831 in the World

South San Francisco, CA, United States of America

Arris Pharmaceutical Corporation

Forward Citations = 390

28 inventors:

Charles R Johnson (4 out of 5 patents)

Derek Hudson (3 out of 11 patents)

Lutz B Giebel (3 out of 3 patents)

4. James M Clark (2 out of 9 patents)

5. David Chapman (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arris Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/arris-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]